Rankings
▼
Calendar
IDXX
IDEXX Laboratories, Inc.
$47B
Q2 2018 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$581M
+14.1% YoY
Gross Profit
$332M
57.2% margin
Operating Income
$146M
25.1% margin
Net Income
$109M
18.7% margin
EPS (Diluted)
$1.23
QoQ Revenue Growth
+8.0%
Cash Flow
Operating Cash Flow
$119M
Free Cash Flow
$91M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$1.5B
Total Liabilities
$1.6B
Stockholders' Equity
-$41M
Cash & Equivalents
$175M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$581M
$509M
+14.1%
Gross Profit
$332M
$293M
+13.6%
Operating Income
$146M
$123M
+18.8%
Net Income
$109M
$85M
+27.3%
Revenue Segments
Up Front Customer Loyalty Programs And Volume Commitment Programs
$975M
83%
Reagent Rental Programs
$92M
8%
Instrument Rebate Programs
$61M
5%
Extended Warranties And Post Contract Support
$42M
4%
Geographic Segments
UNITED STATES
$357M
78%
Asia Pacific
$63M
14%
CANADA
$26M
6%
Latin America
$13M
3%
← FY 2018
All Quarters
Q3 2018 →
IDXX Q2 2018 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena